2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Pain
1
Neoplasms
1
Constipation
1
Cancer Pain
1
Interventions
alvimopan
6
tegaserod
3
naloxegol
2
Standard of Care
2
Naloxone
2
polyethylene glycol 3350
1
oxycodone-acetaminophen
1
oxycodone naloxone combination
1
naldemedine
1
methylnaltrexone
1
ma zi ren wan
1
isatuximab
1
Videotape Recording
1
Tramadol
1
Sutures
1
Surveys and Questionnaires
1
Surgical Instruments
1
Sennosides
1
Quality of Life
1
Proteins
1
Phenolphthalein
1
Oxycodone
1
Orphenadrine
1
Octreotide
1
Nicotine
1
Morphine
1
Methadone
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Constipation
×
oxycodone naloxone combination
×
Clear all
NCT01014559
2015-09-28
OXN3505
Mundipharma SAS
Phase 3
Terminated
225 enrolled